Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.09Current Ratio
VS
Market
Sector
Industry
History
$ 0.74Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information
Ticker
GTBPCompany Name
GT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGT BIOPHARMA INC - Current Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GTBP - Current Ratio Historical data
| Date | Current Assets | Current Ratio | Current Liabilities |
|---|---|---|---|
| 6/30/2025 | $ 7.12M | 3.09 | $ 2.31M |
| 3/31/2025 | $ 2.66M | 0.73 | $ 3.64M |
| 12/31/2024 | $ 4.23M | 0.72 | $ 5.9M |
| 9/30/2024 | $ 6.76M | 1.45 | $ 4.66M |
| 6/30/2024 | $ 9.27M | 2.47 | $ 3.76M |
| 3/31/2024 | $ 9.88M | 2.15 | $ 4.6M |
| 12/31/2023 | $ 14.06M | 2.12 | $ 6.63M |
| 9/30/2023 | $ 16.05M | 3.15 | $ 5.09M |
| 6/30/2023 | $ 18.02M | 3.72 | $ 4.84M |
| 3/31/2023 | $ 19.94M | 4.89 | $ 4.08M |
Key Performance Insights, Last 5 Years
- GT BIOPHARMA INC's latest trailing twelve months (TTM) Current Ratio stands at 0.03.
- Over the past 5 years, GT BIOPHARMA INC's average Current Ratio has been 3.49.
- The median Current Ratio for GT BIOPHARMA INC during this period was 2.97
- GT BIOPHARMA INC reached its highest Current Ratio over the past 5 years at 12.08.
- The lowest Current Ratio recorded by GT BIOPHARMA INC in the same timeframe 0.03
Similar metrics to LiabilitesC:
- Working Capital - [Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
- Cash Ratio - [Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
Definition of Current Ratio
[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].AssetsC / LiabilitesC
(=) Current Ratio Current Ratio for GT BIOPHARMA INC is calculated as follows: AssetsC [ $ 833K ] / LiabilitesC [ $ 30.69M ]
(=) Current Ratio [ 0.03 ] GTBP - Current Ratio, Last 5 years
0.03
Minimum
Sep 30, 2020
12.08
Maximum
Jun 30, 2021
3.49
Average
2.97
Median
Current Ratio Benchmark AnalysisMarket
The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
| filtered constituents | 3.2K |
|---|---|
| min | 0 |
| max | 6.79 |
| average | 2.02 |
| median | 1.62 |
| std | 1.44 |